Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2025-12-25 @ 9:32 PM
NCT ID: NCT01556451
Description: None
Frequency Threshold: 5
Time Frame: Up to 42 days postvaccination
Study: NCT01556451
Study Brief: ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Zoster Vaccine Live Single subcutaneous injection of 0.65 mL in the deltoid region of arm on Day 1 None None 3 180 96 180 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Anal Fistula SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 15.0 View
Gastric Polyps SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 15.0 View
Spinal Compression Fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA 15.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Injection-Site Erythema SYSTEMATIC_ASSESSMENT General disorders MedDRA 15.0 View
Injection-Site Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 15.0 View
Injection-Site Swelling SYSTEMATIC_ASSESSMENT General disorders MedDRA 15.0 View